针对JAK-STAT通路的小分子药物发现
You Lv1, Pengbing Mi2, Jeffrey J Babon3
1Center for Molecular Biosciences and Non-Communicable Diseases Research, Xi'an University of Science and Technology, Xi'an, Shaanxi 710054, China; Xi'an Amazinggene Co., Ltd, Xi'an, Shaanxi 710026, China.
Pharmacological research
|May 22, 2024
概括
简氏激酶-STAT通路对于细胞信号传递和恒温至关重要. 本综述详细介绍了针对这种途径的药物发现策略,用于治疗癌症和自身免疫性疾病等疾病.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 简氏酶信号转换器和转录激活器 (JAK-STAT) 途径对于细胞因子信号传递至关重要,影响血液形成,免疫平衡和组织平衡.
- JAK-STAT通路的失调与免疫缺陷,自身免疫性疾病,血液学疾病和癌症有关.
研究的目的:
- 审查和巩固针对JAK-STAT途径的关键药物发现策略.
- 推进对用于JAK-STAT信号相关疾病的小分子干预的理解.
主要方法:
- 关于JAK-STAT途径研究和药物开发的文献综述.
- 分析小分子抑制剂及其治疗应用.
- 药物发现方法的巩固针对关键途径节点.
主要成果:
- 已经批准了超过10种针对JAK-STAT途径的小分子药物,还有更多在临床试验中.
- 像托法西提尼布和鲁克索利提尼布这样的JAK抑制剂在治疗诸如风湿性关节炎和骨髓纤维化等疾病方面表现出有效性.
- 用不同的策略来调节JAK-STAT信号,从受体相互作用到转录因子激活.
结论:
- 在各种疾病中,JAK-STAT通路具有显著的治疗潜力.
- 针对JAK-STAT途径的小分子干预是制药研究的一个快速发展的领域.
- 对JAK-STAT信号调制的持续研究预计将为一系列疾病提供创新的治疗方法.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


